Katherine Buzzard - Concepedia

Author

Katherine Buzzard

Also Known As

Buzzard, Katherine, K Buzzard, K. Buzzard, Katherine A Buzzard, Katherine A. Buzzard, Katherine Buzzard, MSBase Study Group Authors, Pierre Grammond

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Melbourne The Royal Melbourne Hospital Monash University Hospital Universitario Virgen Macarena Box Hill Hospital

About

Katherine Buzzard is an author at The University of Melbourne specializing in medicine, multiple sclerosis, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	787
2	Public Health	3	3	84
3	Health Sciences	1	1	401
4	Natural Sciences	1	1	138
5	Nursing	1	1	17

Katherine Buzzard

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Defining secondary progressive multiple sclerosis Johannes Lorscheider, Katherine Buzzard, Vilija Jokubaitis, Brain Neurological DisorderDisabilityClinical NeurologyNeurological ProgressNeurological Rehabilitation	2016	401
Heat Shock Protein 72 Modulates Pathways of Stress-induced Apoptosis Katherine Buzzard, Amato J. Giaccia, Marilyn Killender, Journal of Biological Chemistry	1998	282
Hsp72 Inhibits Apoptosis Upstream of the Mitochondria and Not through Interactions with Apaf-1 Rohan Steel, J.P. Doherty, Katherine Buzzard, Journal of Biological Chemistry MitophagyApoptosisCell DeathMolecular BiologyRedox Biology	2004	138
Risk of relapse phenotype recurrence in multiple sclerosis Tomáš Kalinčík, Katherine Buzzard, Vilija Jokubaitis, Multiple Sclerosis Journal	2014	105
Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial John Foley, Gilles Defer, Lana Zhovtis Ryerson, The Lancet Neurology Relapsing-remitting Multiple SclerosisClinical NeurologyClinical TrialsNeurological ProgressTreatment Option	2022	103
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis Izanne Roos, Stella Hughes, Gavin McDonnell, JAMA Neurology	2023	55
Hsp72 Inhibits Fas-mediated Apoptosis Upstream of the Mitochondria in Type II Cells Nicholas J. Clemons, Katherine Buzzard, Rohan Steel, Journal of Biological Chemistry	2005	51
Defining secondary progressive multiple sclerosis Johannes Lorscheider, Katherine Buzzard, Alexandre Prat, Own your potential (DEAKIN)	2016	49
Predicting Infection Risk in Multiple Sclerosis Patients Treated with Ocrelizumab: A Retrospective Cohort Study Nabil Seery, Sifat Sharmin, Vivien Li, CNS Drugs Retrospective Cohort StudyAutoimmune DiseaseDisease ProgressionClinical Infectious DiseaseMedicine	2021	41
Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression Edward De Brouwer, Thijs Becker, Yves Moreau, Computer Methods and Programs in Biomedicine Disease ProgressionMedicinePredictive AnalyticsDisabilityLongitudinal Machine	2021	41

Page 1